Task: Answer the multiple-choice question.
Question: Which drug exhibits a -8.275% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
(a) CC1CC(C)CN(CCCNC(=O)c2ccc3nc(N4CCCCC4)sc3c2)C1
(b) COCCn1c(=NC(=O)CCS(=O)(=O)c2ccccc2)sc2cc(F)ccc21
Answer: b. COCCn1c(=NC(=O)CCS(=O)(=O)c2ccccc2)sc2cc(F)ccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COCCn1c(=NC(=O)CCS(=O)(=O)c2ccccc2)sc2cc(F)ccc21
COCCn1c(=NC(=O)CCS(=O)(=O)c2ccccc2)sc2cc(F)ccc21
3-(benzenesulfonyl)-N-[6-fluoro-3-(2-methoxyethyl)-1,3-benzothiazol-2-ylidene]propanamide